Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications development patient reported assessment identify placebo responders generalized anxiety
… she has worked in the hospital setting, both to provide patient care and to conduct studies of clinical …
… performs primary and secondary research to support the development of evidence-based dossiers, systematic literature … reviews, landscaping activities, health technology assessment (HTA) submissions, outcomes research strategies, … and digital technologies). She has also led the development of several Cochrane systematic reviews on a range …
… Solutions researchers will be presented at EAHAD 2023. Patient experience with efanesoctocog alfa: results from the …
… Cardiovascular Ljungskile, Sweden PhD, Health Technology Assessment Linköping University, Linköping, Sweden MS, … have later been used in the company's health technology assessment submissions. Dr. Brodtkorb has a strong experience …
… involved in primary and secondary research to support the development of evidence-based dossiers, systematic and targeted literature reviews, health technology assessment submissions (including Nordic submissions), and … Before joining RTI-HS, Ms. Gildea was a health technology assessment analyst at the National Institute for Health and …
… studies, such as retrospective and prospective patient chart review, feasibility assessment, burden-of-illness, and patient behavioral surveys. as well as qualitative …
… and editors who collaborate with researchers on the development of publications and posters. She has 16 years of experience in …
… of cardiovascular diseases and diabetes, as well as in the development of study protocols, data analysis, and laboratory …
How Much Does TLV Value Rarity? A Review of Reimbursement Maria Kinderås, MSc Senior Associate, Market Access and Outcomes Strategy Transcript Orphan drug reimbursement continues to pose significant challenges for Swedish decision-makers – due often to …
Effects of Continuous Use of Antidepressants on Dementia The effect of continuous use of antidepressants, with or without anticholinergic properties, for at least 4 months versus no treatment on the incidence of dementia: a target trial emulation. Forns …